- Home
- IPAR vs PTGX Comparison
IPAR vs PTGX Comparison
Compare IPAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPAR
- PTGX
- Stock Information
- Founded
- IPAR 1982
- PTGX 2006
- Country
- IPAR United States
- PTGX United States
- Employees
- IPAR N/A
- PTGX N/A
- Industry
- IPAR Package Goods/Cosmetics
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- IPAR Consumer Discretionary
- PTGX Health Care
- Exchange
- IPAR Nasdaq
- PTGX Nasdaq
- Market Cap
- IPAR 3.1B
- PTGX 5.0B
- IPO Year
- IPAR 1988
- PTGX 2016
- Fundamental
- Price
- IPAR $87.38
- PTGX $79.54
- Analyst Decision
- IPAR Strong Buy
- PTGX Strong Buy
- Analyst Count
- IPAR 5
- PTGX 9
- Target Price
- IPAR $145.60
- PTGX $86.22
- AVG Volume (30 Days)
- IPAR 241.4K
- PTGX 1.3M
- Earning Date
- IPAR 11-05-2025
- PTGX 11-06-2025
- Dividend Yield
- IPAR 3.66%
- PTGX N/A
- EPS Growth
- IPAR 9.68
- PTGX N/A
- EPS
- IPAR 5.13
- PTGX 0.72
- Revenue
- IPAR $1,463,838,000.00
- PTGX $209,217,000.00
- Revenue This Year
- IPAR $4.04
- PTGX N/A
- Revenue Next Year
- IPAR $5.16
- PTGX $140.23
- P/E Ratio
- IPAR $17.05
- PTGX $110.44
- Revenue Growth
- IPAR 3.12
- PTGX N/A
- 52 Week Low
- IPAR $86.50
- PTGX $33.31
- 52 Week High
- IPAR $148.15
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- IPAR 29.75
- PTGX 62.21
- Support Level
- IPAR $87.64
- PTGX $75.44
- Resistance Level
- IPAR $92.20
- PTGX $80.43
- Average True Range (ATR)
- IPAR 2.86
- PTGX 2.61
- MACD
- IPAR -0.36
- PTGX -0.23
- Stochastic Oscillator
- IPAR 6.83
- PTGX 89.38
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.